BRIEF published on 12/23/2024 at 06:35, 29 days ago Siegfried AG réaffirmé dans l'indice Dow Jones Sustainability Index Europe Industrie Pharmaceutique Siegfried AG Performances ESG Initiatives En Matière De Développement Durable Indice De Durabilité Dow Jones
BRIEF published on 12/23/2024 at 06:35, 29 days ago Siegfried AG Reaffirmed in Dow Jones Sustainability Index Europe Pharmaceutical Industry Sustainability Initiatives ESG Performance Siegfried AG Dow Jones Sustainability Index
PRESS RELEASE published on 12/23/2024 at 06:30, 29 days ago Siegfried once again confirmed in the Dow Jones Sustainability Index Europe Siegfried AG confirmed in Dow Jones Sustainability Index Europe for fourth consecutive year, signaling strong ESG performance and commitment to sustainability Sustainability ESG Performance Siegfried AG Dow Jones Sustainability Index Europe Siegfried Group
BRIEF published on 12/06/2024 at 06:35, 1 month 15 days ago Changements dans la direction de Siegfried AG Stratégie De Croissance Industrie Pharmaceutique Siegfried AG Changements Exécutifs Rôles De Direction
BRIEF published on 12/06/2024 at 06:35, 1 month 15 days ago Changes in Siegfried AG's Executive Leadership Growth Strategy Pharmaceutical Industry Executive Changes Leadership Roles Siegfried AG
PRESS RELEASE published on 12/06/2024 at 06:30, 1 month 15 days ago Changes in Siegfried's senior management team Siegfried AG announces changes in senior management team, including new Chief Scientific Officer, Chief Human Resources Officer, and Chief Legal and Sustainability Officer Chief Scientific Officer Senior Management Team Siegfried AG Chief Human Resources Officer Chief Legal And Sustainability Officer
BRIEF published on 11/19/2024 at 07:08, 2 months 1 day ago Siegfried ouvre un nouveau centre de recherche et développement de substances médicamenteuses à Evionnaz Industrie Pharmaceutique Siegfried AG Substances Médicamenteuses Evionnaz Centre De R&D
BRIEF published on 11/19/2024 at 07:08, 2 months 1 day ago Siegfried Opens New R&D Center for Drug Substances in Evionnaz Pharmaceutical Industry Siegfried AG Drug Substances R&D Center Evionnaz
PRESS RELEASE published on 11/19/2024 at 07:03, 2 months 2 days ago Siegfried opens new global R&D Center for Drug Substances in Evionnaz Siegfried inaugurates new R&D Center for Drug Substances in Evionnaz, Switzerland, enhancing global development capabilities and supporting EVOLVE+ strategy Pharmaceutical Industry Drug Substances Siegfried R&D Center Evionnaz
BRIEF published on 11/12/2024 at 06:35, 2 months 9 days ago DINAMIQS Expands with New Lab in Zurich Cell And Gene Therapy DINAMIQS Lab Siegfried Expansion Viral Vector Manufacturing Bio-Technopark Zurich
Published on 01/20/2025 at 20:30, 10 hours 35 minutes ago TaxBandits PRO Features Empower Tax Professionals To Streamline 1099, W-2, 94x, and ACA Filings for the 2024 Tax Year
Published on 01/20/2025 at 20:30, 10 hours 35 minutes ago Taranis Acquires 100% Interest in 1,634 Ha Property Adjoining Thor
Published on 01/20/2025 at 19:00, 12 hours 5 minutes ago Polaris Renewable Energy Announces Q4 and Annual 2024 Financial Results Release Date and Investor Call Details
Published on 01/20/2025 at 16:10, 14 hours 55 minutes ago Game-Changing Partnership Set to Disrupt Inman Event
Published on 01/20/2025 at 14:30, 16 hours 35 minutes ago Wolfden Sells Timberland Parcel for $2.1 Million in Non-Dilutive Financing
Published on 01/21/2025 at 06:58, 6 minutes ago DocMorris grows 6.7 per cent in 2024 and accelerates Rx growth in the fourth quarter
Published on 01/21/2025 at 06:29, 35 minutes ago Avolta debuts in Tunisia with new contract for fifteen duty-free stores across five airports
Published on 01/21/2025 at 04:59, 2 hours 5 minutes ago Alibaba Cloud Announced the Latest AI Models, Tools and Infrastructure Available to Drive More Efficient Global AI Community
Published on 01/20/2025 at 20:56, 10 hours 8 minutes ago Artnet: Annual General Meeting 2024 on February 27, 2025, Expanded Supervisory Board and New, Strong Supervisory Board Candidates
Published on 01/21/2025 at 07:00, 5 minutes ago Biophytis et AskHelpU signent un accord de co-développement dans les maladies rares neuromusculaires en Chine
Published on 01/21/2025 at 07:00, 5 minutes ago Biophytis and AskHelpU Sign a Co-Development Agreement in Rare Neuromuscular Diseases in China
Published on 01/20/2025 at 18:49, 12 hours 15 minutes ago Reporting on share buyback transactions carried out between January 13 and January 16, 2025
Published on 01/20/2025 at 18:49, 12 hours 15 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 13 et le 16 janvier 2025
Published on 01/20/2025 at 18:27, 12 hours 37 minutes ago Déclaration des transactions sur actions propres réalisées du 13 au 17 janvier 2025
